1-(1-Methylethyl)-3-(1-methyl-1H-indol-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine manufacturers
|
| | 1-(1-Methylethyl)-3-(1-methyl-1H-indol-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Basic information |
| | 1-(1-Methylethyl)-3-(1-methyl-1H-indol-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Chemical Properties |
| Boiling point | 564.9±45.0 °C(Predicted) | | density | 1.37±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted) | | pka | 4.26±0.30(Predicted) |
| | 1-(1-Methylethyl)-3-(1-methyl-1H-indol-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Usage And Synthesis |
| Uses | CpCDPK1/TgCDPK1-IN-3 (Compound 20) is a CpCDPK1 and TgCDPK1 inhibitor with IC50 values of 0.003 and 0.0036 μM, respectively. CpCDPK1/TgCDPK1-IN-3 can be used in the research of apicomplexan protozoa-related diseases, such as the research of T. gondii, C. parvum and C. hominus infection[1]. | | References | [1] Wesley C. Van Voorhis, et al. Compositions And Methods For Treating Toxoplasmosis, Cryptosporidiosis, And Other Apicomplexan Protozoan Related Diseases. US20130018040A1. |
| | 1-(1-Methylethyl)-3-(1-methyl-1H-indol-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Preparation Products And Raw materials |
|